(2) demonstrated that eccDNA (especially ecDNA, megabase-scale subtypes) was prevalent across cancers such as glioblastoma and colorectal cancer, often harboring oncogenes (e.g., MYC and EGFR) to drive aggressive phenotypes. This evidence concerns the gene EGFR and glioblastoma.